This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

RNA Leaders USA
New Data, Case Studies & Partners
September 4th-5th, 2024San Diego Convention Center, USA

Todd Chappell
COO at Korro Bio
Speaker

Profile

Todd Chappell, chief operating officer, brings twenty years of product development and product strategy experience. He previously served as senior vice president of strategy and portfolio planning at Korro Bio.Todd is a veteran industry executive who has led several early-stage therapeutic programs from discovery stage through to clinical trials. Most recently, he served as CEO for two seed-staged companies, Rasio Therapeutics, Inc. and Perceptive Navigation, LLC. Prior to being CEO, Mr. Chappell managed a portfolio of start-up pharmaceutical and medical device companies as an entrepreneur-in-residence at a private-public partnership involving Johns Hopkins University, National Institutes of Health, Medimmune, NEA, and SROne. From 2009 to 2012, Todd ran Shape Pharmaceuticals, Inc., a portfolio company of HealthCare Ventures, LLC, where he oversaw all day-to-day operations for the development of a novel HDAC inhibitor for Cutaneous-T-Cell-Lymphoma. Prior to Shape, Mr. Chappell was at CombinatoRx, Inc. for eight years and served as Executive Director of New Products. In that role, Mr. Chappell led the advancement of three programs from assay stage into human clinical studies.Todd holds a B.S. from University of California at Los Angeles and a MBA from Boston University.

Agenda Sessions

  • USING A NOVEL ADAR EDITING PLATFORM TO ADDRESS UNMET NEEDS IN LIVER AND CNS THERAPEUTICS

    9:25am